Buyer for a preclinical CRO in Europe

Company to buy

Industry: Pharma
Subindustry: Clinical Research Organization (CRO)
Revenue: 2-20 million EUR
Location: Europe
#CFIE PHB308

Overview of buyer for a preclinical CRO in Europe

Established over 15 years ago, This buyer is an independent research and testing facility dedicated to delivering high-impact data in dermatology and allied fields. Additionally, it is a 360° service institute that specializes in safety and efficacy clinical studies and claims substantiation, tailored for beauty and healthcare research for global brands. The team comprises skilled medical specialists, life science professionals, and management and R&D experts. Above all, the company has built a robust network of over 40 dermatology sites across diverse regions, ensuring comprehensive and varied research opportunities. The buyer aims to extend its services in Europe through acquisitions that align with its strategic goals of expanding its research capabilities and client base.

Profile (strategy) of buyer for a preclinical CRO in Europe

The buyer is a leading entity in the pharmaceutical and biotechnology sectors, focusing on innovation and excellence in clinical research. Their strategy is to integrate acquired companies to leverage synergies and enhance overall service offerings. The buyer is particularly interested in companies that have a strong operational track record, a skilled workforce, and advanced technological platforms.

Subscribe as an interested seller

Activities of suitable targets

The buyer is interested in acquiring a medium-sized CRO that offers a comprehensive range of services, including:

post-authorization safety studies
pharmacokinetic/pharmacodynamic studies
drug utilization studies and
assistance with product registration
Customized research services tailored to specific therapeutic areas

The target should have a proven track record in delivering high-quality clinical research solutions and a diversified client base across the pharmaceutical and medical device sectors.

Highlights of buyer for a preclinical CRO in Europe

Focuses on expanding research capabilities and enhancing service quality.
Interested in medium-sized CROs with a strong market presence in Europe.
Seeks to acquire companies with innovative research technologies and methodologies.
Financially robust with a strategic plan for growth through acquisition.
Committed to maintaining high standards of quality and compliance in all business practices.

More information on this buyer for a preclinical CRO in Europe

Please get in touch if you are interested in learning more about this buyer for a preclinical CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CRO buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.